NCT00558675
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +32 more
- Locations
-
- Hadassah-Hebrew University Medical Center Jerusalem, Israel
Clinical trial condition
Hematologic Neoplasms
Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.
1,027 public trials
268 recruiting studies
Hematologic Neoplasms trial results
NCT01222780
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Tumors, +40 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00001872
- Conditions
- Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasm, +5 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00001623
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01251575
- Conditions
- Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, +67 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1) Duarte, California, United States
- Georgia Regents University SC-2 Augusta, Georgia, United States
- Dana Farber Cancer Institute Reg. Ped Boston, Massachusetts, United States
- University of Utah / Huntsman Cancer Institute SC-2 Salt Lake City, Utah, United States
NCT00185692
- Conditions
- Blood Cancer, CLL, Graft Versus Host Disease, +18 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Completed
Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
NCT01324323
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Canon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research UK London, United Kingdom
Completed
Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
NCT01324310
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research UK London, United Kingdom
NCT02164071
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Bronchial Diseases, +31 more
- Locations
-
- Hospital Txagorritxu Vitoria-Gasteiz, Alava, Spain
- Hospital Sant Joan de Deu Espluges de Llobregat, Barcelona, Spain
- Hospital Duran I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital Parc Tauli Sabadell, Barcelona, Spain